National Health (Weighted average disclosed price—third transitional disclosure cycle) Determination 2012 (PB 12 of 2012)
as amended
made under subsection 99ADB(4) and paragraph 99ADH(1)(aa) of the
National Health Act 1953
Compilation start date: 26 July 2012
Includes amendments up to: PB 51 of 2012
About this compilation
This compilation
This is a compilation of the National Health (Weighted average disclosed price—third transitional disclosure cycle) Determination 2012 (PB 12 of 2012) as in force on 26 July 2012. It includes any commenced amendment affecting the compilation to that date.
This compilation was prepared on 19 August 2013.
The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of each amended provision.
Uncommenced amendments
The effect of uncommenced amendments is not reflected in the text of the compiled law but the text of the amendments is included in the endnotes.
Application, saving and transitional provisions for provisions and amendments
If the operation of a provision or amendment is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.
Modifications
If a provision of the compiled law is affected by a modification that is in force, details are included in the endnotes.
Provisions ceasing to have effect
If a provision of the compiled law has expired or otherwise ceased to have effect in accordance with a provision of the law, details are included in the endnotes.
Contents
1 Name of Determination
2 Commencement
3 Revocation
4 Definitions
5 Weighted average disclosed price for brands of pharmaceutical items—unadjusted price reduction is at least 10%
6 Weighted average disclosed price for brands of pharmaceutical items—unadjusted price reduction is less than 10%
7 Adjusted approved ex-manufacturer price for brands of pharmaceutical items—unadjusted price reduction is at least 10%
8 Adjusted approved price to pharmacists for brands of pharmaceutical items—unadjusted price reduction is at least 10%
9 Reduction Day
Schedule 1—Brands of pharmaceutical items—unadjusted price reduction is at least 10%
Schedule 2—Brands of pharmaceutical items—unadjusted price reduction is less than 10%
Endnotes
Endnote 1—About the endnotes
Endnote 2—Abbreviation key
Endnote 3—Legislation history
Endnote 4—Amendment history
Endnote 5—Uncommenced amendments [none]
Endnote 6—Modifications [none]
Endnote 7—Misdescribed amendments [none]
Endnote 8—Miscellaneous [none]
(1) This Determination is the National Health (Weighted average disclosed price—third transitional disclosure cycle) Determination 2012.
(2) This Determination may also be cited as PB 12 of 2012.
This Determination commences on the day after it is registered.
The Determination titled ‘Determination made pursuant to subsections 99ADB(4) and 99ADB(5) of the National Health Act 1953’ made on 24 January 2011 and also cited as PB 5 of 2011 is revoked.
In this Determination:
Act means the National Health Act 1953.
adjusted approved ex‑‑manufacturer price has the same meaning as in subsection 99ADB(1) of the Act.
adjusted approved price to pharmacists has the same meaning as in subsection 99ADB(1) of the Act.
third transitional disclosure cycle has the same meaning as in Part 2 Transitional, regulation 4, of the National Health (Pharmaceutical Benefits) Amendment Regulations 2010 (No.5) (SLI 296 of 2010).
unadjusted price reduction has the same meaning as in subsection 99ADB(1) of the Act.
weighted average disclosed price has the same meaning as in subsection 99ADB(1) of the Act.
For subsection 99ADB(4) of the Act, the weighted average disclosed price specified in column 3 of an item in Schedule 1 is the weighted average disclosed price for the brand of pharmaceutical item specified in column 2 of the same item in Schedule 1.
For subsection 99ADB(4) of the Act, the weighted average disclosed price specified in column 3 of an item in Schedule 2 is the weighted average disclosed price for the brand of pharmaceutical item specified in column 2 of the same item in Schedule 2.
For paragraph 99ADB(4) of the Act, the adjusted approved ex-manufacturer price for a brand of pharmaceutical item specified in column 2 of Schedule 1 is an amount equal to the amount of the weighted average disclosed price of that brand of pharmaceutical item determined under section 5 of this instrument.
For paragraph 99ADB(4) of the Act, the adjusted approved price to pharmacists specified in column 4 of an item in Schedule 1 is the adjusted approved price to pharmacists for the brand of pharmaceutical item specified in column 2 of the same item in Schedule 1.
For paragraph 99ADH(1)(aa) of the Act, a brand of pharmaceutical item in the third transitional disclosure cycle with a data collection period ending at the end of 31 January 2012 has a reduction day of 1 August 2012.
Schedule 1—Brands of pharmaceutical items—unadjusted price reduction is at least 10%
Column 1 | Column 2 | Column 3 | Column 4 | |||
Item | Brand of Pharmaceutical Item | Weighted average disclosed price | Adjusted approved price to pharmacists | |||
| Listed Drug | Form | Manner of administration | Brand |
|
|
1 | Amisulpride | Tablet 100 mg | Oral | Amisulpride 100 Winthrop | 17.33 | 18.63 |
2 | Amisulpride | Tablet 100 mg | Oral | Amisulpride Sandoz | 17.33 | 18.63 |
3 | Amisulpride | Tablet 100 mg | Oral | APO‑‑Amisulpride | 17.33 | 18.63 |
4 | Amisulpride | Tablet 100 mg | Oral | Solian 100 | 17.33 | 18.63 |
5 | Amisulpride | Tablet 100 mg | Oral | Sulprix | 17.33 | 18.63 |
6 | Amisulpride | Tablet 200 mg | Oral | Amisulpride 200 Winthrop | 74.64 | 80.25 |
7 | Amisulpride | Tablet 200 mg | Oral | Amisulpride Sandoz | 74.64 | 80.25 |
8 | Amisulpride | Tablet 200 mg | Oral | APO‑‑Amisulpride | 74.64 | 80.25 |
9 | Amisulpride | Tablet 200 mg | Oral | Solian 200 | 74.64 | 80.25 |
10 | Amisulpride | Tablet 200 mg | Oral | Sulprix | 74.64 | 80.25 |
11 | Amisulpride | Tablet 400 mg | Oral | Amipride 400 | 135.35 | 145.53 |
12 | Amisulpride | Tablet 400 mg | Oral | Amisulpride 400 Winthrop | 135.35 | 145.53 |
13 | Amisulpride | Tablet 400 mg | Oral | Amisulpride Sandoz | 135.35 | 145.53 |
14 | Amisulpride | Tablet 400 mg | Oral | APO‑‑Amisulpride | 135.35 | 145.53 |
15 | Amisulpride | Tablet 400 mg | Oral | Solian 400 | 135.35 | 145.53 |
16 | Amisulpride | Tablet 400 mg | Oral | Sulprix | 135.35 | 145.53 |
17 | Bisoprolol | Tablet containing bisoprolol fumarate 10 mg | Oral | APO-Bisoprolol | 44.24 | 47.57 |
17A | Bisoprolol | Tablet containing bisoprolol fumarate 10 mg | Oral | Beprol 10 | 44.24 | 47.57 |
18 | Bisoprolol | Tablet containing bisoprolol fumarate 10 mg | Oral | Bicard 10 | 44.24 | 47.57 |
19 | Bisoprolol | Tablet containing bisoprolol fumarate 10 mg | Oral | Bicor | 44.24 | 47.57 |
19A | Bisoprolol | Tablet containing bisoprolol fumarate 10 mg | Oral | Biso 10 | 44.24 | 47.57 |
20 | Bisoprolol | Tablet containing bisoprolol fumarate 10 mg | Oral | Bisoprolol GH | 44.24 | 47.57 |
21 | Bisoprolol | Tablet containing bisoprolol fumarate 10 mg | Oral | Bisoprolol Pfizer | 44.24 | 47.57 |
22 | Bisoprolol | Tablet containing bisoprolol fumarate 10 mg | Oral | Bisoprolol Sandoz | 44.24 | 47.57 |
23 | Bisoprolol | Tablet containing bisoprolol fumarate 10 mg | Oral | Bispro 10 | 44.24 | 47.57 |
24 | Bisoprolol | Tablet containing bisoprolol fumarate 10 mg | Oral | Chem mart Bisoprolol | 44.24 | 47.57 |
25 | Bisoprolol | Tablet containing bisoprolol fumarate 10 mg | Oral | Terry White Chemists Bisoprolol | 44.24 | 47.57 |
26 | Bisoprolol | Tablet containing bisoprolol fumarate 2.5 mg | Oral | APO‑‑Bisoprolol | 28.32 | 30.45 |
26A | Bisoprolol | Tablet containing bisoprolol fumarate 2.5 mg | Oral | Beprol 2.5 | 28.32 | 30.45 |
27 | Bisoprolol | Tablet containing bisoprolol fumarate 2.5 mg | Oral | Bicard 2.5 | 28.32 | 30.45 |
28 | Bisoprolol | Tablet containing bisoprolol fumarate 2.5 mg | Oral | Bicor | 28.32 | 30.45 |
28A | Bisoprolol | Tablet containing bisoprolol fumarate 2.5 mg | Oral | Biso 2.5 | 28.32 | 30.45 |
29 | Bisoprolol | Tablet containing bisoprolol fumarate 2.5 mg | Oral | Bisoprolol GH | 28.32 | 30.45 |
30 | Bisoprolol | Tablet containing bisoprolol fumarate 2.5 mg | Oral | Bisoprolol Pfizer | 28.32 | 30.45 |
31 | Bisoprolol | Tablet containing bisoprolol fumarate 2.5 mg | Oral | Bisoprolol Sandoz | 28.32 | 30.45 |
32 | Bisoprolol | Tablet containing bisoprolol fumarate 2.5 mg | Oral | Bispro 2.5 | 28.32 | 30.45 |
33 | Bisoprolol | Tablet containing bisoprolol fumarate 2.5 mg | Oral | Chem mart Bisoprolol | 28.32 | 30.45 |
34 | Bisoprolol | Tablet containing bisoprolol fumarate 2.5 mg | Oral | Terry White Chemists Bisoprolol | 28.32 | 30.45 |
35 | Bisoprolol | Tablet containing bisoprolol fumarate 5 mg | Oral | APO‑‑Bisoprolol | 35.39 | 38.05 |
35A | Bisoprolol | Tablet containing bisoprolol fumarate 5 mg | Oral | Beprol 5 | 35.39 | 38.05 |
36 | Bisoprolol | Tablet containing bisoprolol fumarate 5 mg | Oral | Bicard 5 | 35.39 | 38.05 |
37 | Bisoprolol | Tablet containing bisoprolol fumarate 5 mg | Oral | Bicor | 35.39 | 38.05 |
37A | Bisoprolol | Tablet containing bisoprolol fumarate 5 mg | Oral | Biso 5 | 35.39 | 38.05 |
38 | Bisoprolol | Tablet containing bisoprolol fumarate 5 mg | Oral | Bisoprolol GH | 35.39 | 38.05 |
39 | Bisoprolol | Tablet containing bisoprolol fumarate 5 mg | Oral | Bisoprolol Pfizer | 35.39 | 38.05 |
40 | Bisoprolol | Tablet containing bisoprolol fumarate 5 mg | Oral | Bisoprolol Sandoz | 35.39 | 38.05 |
41 | Bisoprolol | Tablet containing bisoprolol fumarate 5 mg | Oral | Bispro 5 | 35.39 | 38.05 |
42 | Bisoprolol | Tablet containing bisoprolol fumarate 5 mg | Oral | Chem mart Bisoprolol | 35.39 | 38.05 |
43 | Bisoprolol | Tablet containing bisoprolol fumarate 5 mg | Oral | Terry White Chemists Bisoprolol | 35.39 | 38.05 |
44 | Cefalotin | Powder for injection 1 g (as sodium) | Injection | Cefalotin Sandoz | 13.31 | 14.31 |
45 | Cefalotin | Powder for injection 1 g (as sodium) | Injection | Hospira Pty Limited | 13.31 | 14.31 |
46 | Cefalotin | Powder for injection 1 g (as sodium) | Injection | Keflin Neutral | 13.31 | 14.31 |
47 | Doxorubicin | Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 10 mg in 5 mL single dose vial | Injection/intravesical | Accord Doxorubicin | 4.61 | 4.96 |
49 | Doxorubicin | Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 10 mg in 5 mL single dose vial | Injection/intravesical | Doxorubicin Ebewe | 4.61 | 4.96 |
50 | Doxorubicin | Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 10 mg in 5 mL single dose vial | Injection/intravesical | Hospira Pty Limited | 4.61 | 4.96 |
51 | Doxorubicin | Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 100 mg in 50 mL single dose vial | Injection/intravesical | Doxorubicin Ebewe | 38.97 | 41.90 |
53 | Doxorubicin | Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 200 mg in 100 mL single dose vial | Injection/intravesical | Accord Doxorubicin | 77.94 | 83.80 |
54 | Doxorubicin | Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 200 mg in 100 mL single dose vial | Injection/intravesical | Adriamycin | 77.94 | 83.80 |
55 | Doxorubicin | Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 200 mg in 100 mL single dose vial | Injection/intravesical | Doxorubicin Ebewe | 77.94 | 83.80 |
56 | Doxorubicin | Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 50 mg in 25 mL single dose vial | Injection/intravesical | Adriamycin Solution | 19.49 | 20.96 |
57 | Doxorubicin | Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 50 mg in 25 mL single dose vial | Injection/intravesical | Doxorubicin Ebewe | 19.49 | 20.96 |
58 | Doxorubicin | Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 50 mg in 25 mL single dose vial | Injection/intravesical | Hospira Pty Limited | 19.49 | 20.96 |
59 | Escitalopram | Tablet 10 mg (as oxalate) | Oral | APO‑‑Escitalopram | 7.47 | 8.03 |
60 | Escitalopram | Tablet 10 mg (as oxalate) | Oral | Chem mart Escitalopram | 7.47 | 8.03 |
61 | Escitalopram | Tablet 10 mg (as oxalate) | Oral | Escicor 10 | 7.47 | 8.03 |
62 | Escitalopram | Tablet 10 mg (as oxalate) | Oral | Escitalopram GA | 7.47 | 8.03 |
63 | Escitalopram | Tablet 10 mg (as oxalate) | Oral | Escitalopram generichealth | 7.47 | 8.03 |
64 | Escitalopram | Tablet 10 mg (as oxalate) | Oral | Escitalopram‑‑DRLA | 7.47 | 8.03 |
65 | Escitalopram | Tablet 10 mg (as oxalate) | Oral | Esipram | 7.47 | 8.03 |
66 | Escitalopram | Tablet 10 mg (as oxalate) | Oral | Esitalo | 7.47 | 8.03 |
67 | Escitalopram | Tablet 10 mg (as oxalate) | Oral | Lexam 10 | 7.47 | 8.03 |
68 | Escitalopram | Tablet 10 mg (as oxalate) | Oral | Lexapro | 7.47 | 8.03 |
69 | Escitalopram | Tablet 10 mg (as oxalate) | Oral | LoxaLate | 7.47 | 8.03 |
70 | Escitalopram | Tablet 10 mg (as oxalate) | Oral | Pharmacor Escitalopram 10 | 7.47 | 8.03 |
71 | Escitalopram | Tablet 10 mg (as oxalate) | Oral | Terry White Chemists Escitalopram | 7.47 | 8.03 |
72 | Escitalopram | Tablet 20 mg (as oxalate) | Oral | APO‑‑Escitalopram | 7.53 | 8.10 |
73 | Escitalopram | Tablet 20 mg (as oxalate) | Oral | Chem mart Escitalopram | 7.53 | 8.10 |
74 | Escitalopram | Tablet 20 mg (as oxalate) | Oral | Escicor 20 | 7.53 | 8.10 |
75 | Escitalopram | Tablet 20 mg (as oxalate) | Oral | Escitalopram GA | 7.53 | 8.10 |
76 | Escitalopram | Tablet 20 mg (as oxalate) | Oral | Escitalopram generichealth | 7.53 | 8.10 |
77 | Escitalopram | Tablet 20 mg (as oxalate) | Oral | Escitalopram‑‑DRLA | 7.53 | 8.10 |
78 | Escitalopram | Tablet 20 mg (as oxalate) | Oral | Esipram | 7.53 | 8.10 |
79 | Escitalopram | Tablet 20 mg (as oxalate) | Oral | Esitalo | 7.53 | 8.10 |
80 | Escitalopram | Tablet 20 mg (as oxalate) | Oral | Lexam 20 | 7.53 | 8.10 |
81 | Escitalopram | Tablet 20 mg (as oxalate) | Oral | Lexapro | 7.53 | 8.10 |
82 | Escitalopram | Tablet 20 mg (as oxalate) | Oral | LoxaLate | 7.53 | 8.10 |
83 | Escitalopram | Tablet 20 mg (as oxalate) | Oral | Pharmacor Escitalopram 20 | 7.53 | 8.10 |
84 | Escitalopram | Tablet 20 mg (as oxalate) | Oral | Terry White Chemists Escitalopram | 7.53 | 8.10 |
85 | Levetiracetam | Tablet 1 g | Oral | APO‑‑Levetiracetam | 96.84 | 104.12 |
86 | Levetiracetam | Tablet 1 g | Oral | Chem mart Levetiracetam | 96.84 | 104.12 |
87 | Levetiracetam | Tablet 1 g | Oral | Kepcet | 96.84 | 104.12 |
88 | Levetiracetam | Tablet 1 g | Oral | Keppra | 96.84 | 104.12 |
88A | Levetiracetam | Tablet 1 g | Oral | Kerron 1000 | 96.84 | 104.12 |
89 | Levetiracetam | Tablet 1 g | Oral | Kevtam | 96.84 | 104.12 |
90 | Levetiracetam | Tablet 1 g | Oral | Levecetam 1000 | 96.84 | 104.12 |
91 | Levetiracetam | Tablet 1 g | Oral | Levetiracetam generichealth | 96.84 | 104.12 |
92 | Levetiracetam | Tablet 1 g | Oral | Levetiracetam SZ | 96.84 | 104.12 |
93 | Levetiracetam | Tablet 1 g | Oral | Levitaccord | 96.84 | 104.12 |
94 | Levetiracetam | Tablet 1 g | Oral | Levitam 1000 | 96.84 | 104.12 |
95 | Levetiracetam | Tablet 1 g | Oral | Terry White Chemists Levetiracetam | 96.84 | 104.12 |
96 | Levetiracetam | Tablet 250 mg | Oral | APO‑‑Levetiracetam | 34.86 | 37.48 |
97 | Levetiracetam | Tablet 250 mg | Oral | Chem mart Levetiracetam | 34.86 | 37.48 |
98 | Levetiracetam | Tablet 250 mg | Oral | Kepcet | 34.86 | 37.48 |
99 | Levetiracetam | Tablet 250 mg | Oral | Keppra | 34.86 | 37.48 |
99A | Levetiracetam | Tablet 250 mg | Oral | Kerron 250 | 34.86 | 37.48 |
100 | Levetiracetam | Tablet 250 mg | Oral | Kevtam | 34.86 | 37.48 |
101 | Levetiracetam | Tablet 250 mg | Oral | Levecetam 250 | 34.86 | 37.48 |
102 | Levetiracetam | Tablet 250 mg | Oral | Levetiracetam generichealth | 34.86 | 37.48 |
103 | Levetiracetam | Tablet 250 mg | Oral | Levetiracetam SZ | 34.86 | 37.48 |
104 | Levetiracetam | Tablet 250 mg | Oral | Levitaccord | 34.86 | 37.48 |
105 | Levetiracetam | Tablet 250 mg | Oral | Levitam 250 | 34.86 | 37.48 |
106 | Levetiracetam | Tablet 250 mg | Oral | Terry White Chemists Levetiracetam | 34.86 | 37.48 |
107 | Levetiracetam | Tablet 500 mg | Oral | APO‑‑Levetiracetam | 58.12 | 62.49 |
108 | Levetiracetam | Tablet 500 mg | Oral | Chem mart Levetiracetam | 58.12 | 62.49 |
109 | Levetiracetam | Tablet 500 mg | Oral | Kepcet | 58.12 | 62.49 |
110 | Levetiracetam | Tablet 500 mg | Oral | Keppra | 58.12 | 62.49 |
110A | Levetiracetam | Tablet 500 mg | Oral | Kerron 500 | 58.12 | 62.49 |
111 | Levetiracetam | Tablet 500 mg | Oral | Kevtam | 58.12 | 62.49 |
112 | Levetiracetam | Tablet 500 mg | Oral | Levecetam 500 | 58.12 | 62.49 |
113 | Levetiracetam | Tablet 500 mg | Oral | Levetiracetam generichealth | 58.12 | 62.49 |
114 | Levetiracetam | Tablet 500 mg | Oral | Levetiracetam SZ | 58.12 | 62.49 |
115 | Levetiracetam | Tablet 500 mg | Oral | Levitaccord | 58.12 | 62.49 |
116 | Levetiracetam | Tablet 500 mg | Oral | Levitam 500 | 58.12 | 62.49 |
117 | Levetiracetam | Tablet 500 mg | Oral | Terry White Chemists Levetiracetam | 58.12 | 62.49 |
118 | Meloxicam | Capsule 15 mg | Oral | APO‑‑Meloxicam | 9.95 | 10.70 |
119 | Meloxicam | Capsule 15 mg | Oral | Chem mart Meloxicam | 9.95 | 10.70 |
120 | Meloxicam | Capsule 15 mg | Oral | Mobic | 9.95 | 10.70 |
121 | Meloxicam | Capsule 15 mg | Oral | Movalis 15 | 9.95 | 10.70 |
122 | Meloxicam | Capsule 15 mg | Oral | Terry White Chemists Meloxicam | 9.95 | 10.70 |
123 | Meloxicam | Capsule 7.5 mg | Oral | APO‑‑Meloxicam | 6.82 | 7.33 |
124 | Meloxicam | Capsule 7.5 mg | Oral | Chem mart Meloxicam | 6.82 | 7.33 |
125 | Meloxicam | Capsule 7.5 mg | Oral | Mobic | 6.82 | 7.33 |
126 | Meloxicam | Capsule 7.5 mg | Oral | Movalis 7.5 | 6.82 | 7.33 |
127 | Meloxicam | Capsule 7.5 mg | Oral | Terry White Chemists Meloxicam | 6.82 | 7.33 |
128 | Meloxicam | Tablet 15 mg | Oral | Chem mart Meloxicam 15 mg | 9.95 | 10.70 |
129 | Meloxicam | Tablet 15 mg | Oral | GenRx Meloxicam | 9.95 | 10.70 |
130 | Meloxicam | Tablet 15 mg | Oral | Meloxibell | 9.95 | 10.70 |
131 | Meloxicam | Tablet 15 mg | Oral | Meloxicam Ranbaxy | 9.95 | 10.70 |
132 | Meloxicam | Tablet 15 mg | Oral | Meloxicam Sandoz | 9.95 | 10.70 |
133 | Meloxicam | Tablet 15 mg | Oral | Meloxicam‑‑GA | 9.95 | 10.70 |
134 | Meloxicam | Tablet 15 mg | Oral | Mobic | 9.95 | 10.70 |
135 | Meloxicam | Tablet 15 mg | Oral | Movalis 15 | 9.95 | 10.70 |
136 | Meloxicam | Tablet 15 mg | Oral | Moxicam 15 | 9.95 | 10.70 |
137 | Meloxicam | Tablet 15 mg | Oral | Pharmacor Meloxicam 15 | 9.95 | 10.70 |
138 | Meloxicam | Tablet 15 mg | Oral | Terry White Chemists Meloxicam 15 mg | 9.95 | 10.70 |
139 | Meloxicam | Tablet 7.5 mg | Oral | Chem mart Meloxicam 7.5 mg | 6.82 | 7.33 |
140 | Meloxicam | Tablet 7.5 mg | Oral | GenRx Meloxicam | 6.82 | 7.33 |
141 | Meloxicam | Tablet 7.5 mg | Oral | Meloxibell | 6.82 | 7.33 |
142 | Meloxicam | Tablet 7.5 mg | Oral | Meloxicam Ranbaxy | 6.82 | 7.33 |
143 | Meloxicam | Tablet 7.5 mg | Oral | Meloxicam Sandoz | 6.82 | 7.33 |
144 | Meloxicam | Tablet 7.5 mg | Oral | Meloxicam‑‑GA | 6.82 | 7.33 |
145 | Meloxicam | Tablet 7.5 mg | Oral | Mobic | 6.82 | 7.33 |
146 | Meloxicam | Tablet 7.5 mg | Oral | Movalis 7.5 | 6.82 | 7.33 |
147 | Meloxicam | Tablet 7.5 mg | Oral | Moxicam 7.5 | 6.82 | 7.33 |
148 | Meloxicam | Tablet 7.5 mg | Oral | Pharmacor Meloxicam 7.5 | 6.82 | 7.33 |
149 | Meloxicam | Tablet 7.5 mg | Oral | Terry White Chemists Meloxicam 7.5 mg | 6.82 | 7.33 |
151 | Mitozantrone | Injection 20 mg (as hydrochloride) in 10 mL | Injection | Hospira Pty Limited | 106.69 | 114.71 |
152 | Mitozantrone | Injection 20 mg (as hydrochloride) in 10 mL | Injection | Mitozantrone Ebewe | 106.69 | 114.71 |
153 | Mitozantrone | Injection 20 mg (as hydrochloride) in 10 mL | Injection | Onkotrone | 106.69 | 114.71 |
154 | Mitozantrone | Injection 20 mg (as hydrochloride) in 10 mL | Injection | Pfizer Australia Pty Ltd | 106.69 | 114.71 |
155 | Mitozantrone | Injection 25 mg (as hydrochloride) in 12.5 mL | Injection | Onkotrone | 133.29 | 143.31 |
157 | Ondansetron | I.V. injection 4 mg (as hydrochloride dihydrate) in 2 mL | Injection | Ondansetron Alphapharm | 1.93 | 2.08 |
158 | Ondansetron | I.V. injection 4 mg (as hydrochloride dihydrate) in 2 mL | Injection | Ondansetron‑‑Claris | 1.93 | 2.08 |
159 | Ondansetron | I.V. injection 4 mg (as hydrochloride dihydrate) in 2 mL | Injection | Ondaz | 1.93 | 2.08 |
160 | Ondansetron | I.V. injection 4 mg (as hydrochloride dihydrate) in 2 mL | Injection | Onsetron | 1.93 | 2.08 |
162 | Ondansetron | I.V. injection 4 mg (as hydrochloride dihydrate) in 2 mL | Injection | Zofran | 1.93 | 2.08 |
163 | Ondansetron | I.V. injection 8 mg (as hydrochloride dihydrate) in 4 mL | Injection | Ondansetron Alphapharm | 3.06 | 3.29 |
164 | Ondansetron | I.V. injection 8 mg (as hydrochloride dihydrate) in 4 mL | Injection | Ondansetron‑‑Claris | 3.06 | 3.29 |
165 | Ondansetron | I.V. injection 8 mg (as hydrochloride dihydrate) in 4 mL | Injection | Ondaz | 3.06 | 3.29 |
166 | Ondansetron | I.V. injection 8 mg (as hydrochloride dihydrate) in 4 mL | Injection | Onsetron | 3.06 | 3.29 |
168 | Ondansetron | I.V. injection 8 mg (as hydrochloride dihydrate) in 4 mL | Injection | Zofran | 3.06 | 3.29 |
169 | Oxaliplatin | Powder for I.V. infusion 100 mg | Injection | Hospira Pty Limited | 79.14 | 85.09 |
170 | Oxaliplatin | Powder for I.V. infusion 100 mg | Injection | Oxalatin | 79.14 | 85.09 |
171 | Oxaliplatin | Powder for I.V. infusion 100 mg | Injection | Oxaliplatin Actavis | 79.14 | 85.09 |
172 | Oxaliplatin | Powder for I.V. infusion 100 mg | Injection | Oxaliplatin Alphapharm | 79.14 | 85.09 |
173 | Oxaliplatin | Powder for I.V. infusion 100 mg | Injection | Oxaliplatin Ebewe | 79.14 | 85.09 |
174 | Oxaliplatin | Powder for I.V. infusion 100 mg | Injection | Oxaliplatin Link | 79.14 | 85.09 |
176 | Oxaliplatin | Powder for I.V. infusion 100 mg | Injection | Xalox | 79.14 | 85.09 |
177 | Oxaliplatin | Powder for I.V. infusion 50 mg | Injection | Hospira Pty Limited | 40.97 | 44.05 |
178 | Oxaliplatin | Powder for I.V. infusion 50 mg | Injection | Oxalatin | 40.97 | 44.05 |
179 | Oxaliplatin | Powder for I.V. infusion 50 mg | Injection | Oxaliplatin Actavis | 40.97 | 44.05 |
180 | Oxaliplatin | Powder for I.V. infusion 50 mg | Injection | Oxaliplatin Alphapharm | 40.97 | 44.05 |
181 | Oxaliplatin | Powder for I.V. infusion 50 mg | Injection | Oxaliplatin Ebewe | 40.97 | 44.05 |
182 | Oxaliplatin | Powder for I.V. infusion 50 mg | Injection | Oxaliplatin Link | 40.97 | 44.05 |
183 | Oxaliplatin | Powder for I.V. infusion 50 mg | Injection | Xalox | 40.97 | 44.05 |
184 | Oxaliplatin | Solution concentrate for I.V. infusion 100 mg in 20 mL | Injection | DBL Oxaliplatin Concentrate | 79.14 | 85.09 |
185 | Oxaliplatin | Solution concentrate for I.V. infusion 100 mg in 20 mL | Injection | Eloxatin | 79.14 | 85.09 |
185A | Oxaliplatin | Solution concentrate for I.V. infusion 100 mg in 20 mL | Injection | Oxaliccord | 79.14 | 85.09 |
186 | Oxaliplatin | Solution concentrate for I.V. infusion 100 mg in 20 mL | Injection | Oxaliplatin Kabi | 79.14 | 85.09 |
187 | Oxaliplatin | Solution concentrate for I.V. infusion 100 mg in 20 mL | Injection | Oxaliplatin SUN | 79.14 | 85.09 |
188 | Oxaliplatin | Solution concentrate for I.V. infusion 200 mg in 40 mL | Injection | Eloxatin | 157.74 | 169.60 |
189 | Oxaliplatin | Solution concentrate for I.V. infusion 200 mg in 40 mL | Injection | Oxaliplatin SUN | 157.74 | 169.60 |
190 | Oxaliplatin | Solution concentrate for I.V. infusion 50 mg in 10 mL | Injection | DBL Oxaliplatin Concentrate | 40.97 | 44.05 |
191 | Oxaliplatin | Solution concentrate for I.V. infusion 50 mg in 10 mL | Injection | Eloxatin | 40.97 | 44.05 |
191A | Oxaliplatin | Solution concentrate for I.V. infusion 50 mg in 10 mL | Injection | Oxaliccord | 40.97 | 44.05 |
192 | Oxaliplatin | Solution concentrate for I.V. infusion 50 mg in 10 mL | Injection | Oxaliplatin Kabi | 40.97 | 44.05 |
193 | Oxaliplatin | Solution concentrate for I.V. infusion 50 mg in 10 mL | Injection | Oxaliplatin SUN | 40.97 | 44.05 |
194 | Oxybutynin | Tablet containing oxybutynin hydrochloride 5 mg | Oral | Ditropan | 6.44 | 6.92 |
195 | Oxybutynin | Tablet containing oxybutynin hydrochloride 5 mg | Oral | Oxybutynin Sandoz | 6.44 | 6.92 |
196 | Oxybutynin | Tablet containing oxybutynin hydrochloride 5 mg | Oral | Oxybutynin Winthrop | 6.44 | 6.92 |
197 | Perindopril with Indapamide | Tablet containing perindopril arginine 2.5 mg with indapamide hemihydrate 0.625 mg | Oral | Coversyl Plus LD 2.5mg/0.625mg | 6.94 | 7.46 |
198 | Perindopril with Indapamide | Tablet containing perindopril arginine 5 mg with indapamide hemihydrate 1.25 mg | Oral | Coversyl Plus 5mg/1.25mg | 15.59 | 16.76 |
199 | Perindopril with Indapamide | Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg | Oral | Chem mart Perindopril/ Indapamide 4/1.25 | 15.59 | 16.76 |
200 | Perindopril with Indapamide | Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg | Oral | GenRx Perindopril/ Indapamide 4/1.25 | 15.59 | 16.76 |
201 | Perindopril with Indapamide | Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg | Oral | Idaprex Combi 4/1.25 | 15.59 | 16.76 |
202 | Perindopril with Indapamide | Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg | Oral | Indopril Combi 4/1.25 | 15.59 | 16.76 |
203 | Perindopril with Indapamide | Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg | Oral | Perindo Combi 4/1.25 | 15.59 | 16.76 |
204 | Perindopril with Indapamide | Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg | Oral | Perindopril/ Indapamide GH 4/1.25 | 15.59 | 16.76 |
205 | Perindopril with Indapamide | Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg | Oral | Terry White Chemists Perindopril/ Indapamide 4/1.25 | 15.59 | 16.76 |
206 | Prochlorperazine | Tablet containing prochlorperazine maleate 5 mg | Oral | APO‑‑Prochlorperazine | 1.83 | 1.97 |
207 | Prochlorperazine | Tablet containing prochlorperazine maleate 5 mg | Oral | Pharmacor Prozine 5 | 1.83 | 1.97 |
208 | Prochlorperazine | Tablet containing prochlorperazine maleate 5 mg | Oral | ProCalm | 1.83 | 1.97 |
209 | Prochlorperazine | Tablet containing prochlorperazine maleate 5 mg | Oral | Prochlorperazine GH | 1.83 | 1.97 |
210 | Prochlorperazine | Tablet containing prochlorperazine maleate 5 mg | Oral | Prochlorperazine‑‑GA | 1.83 | 1.97 |
211 | Prochlorperazine | Tablet containing prochlorperazine maleate 5 mg | Oral | Prochlorperazine‑‑PS | 1.83 | 1.97 |
212 | Prochlorperazine | Tablet containing prochlorperazine maleate 5 mg | Oral | Stemetil | 1.83 | 1.97 |
213 | Prochlorperazine | Tablet containing prochlorperazine maleate 5 mg | Oral | Stemzine | 1.83 | 1.97 |
Schedule 2—Brands of pharmaceutical items—unadjusted price reduction is less than 10%
Item | Brand of Pharmaceutical Item | Weighted average disclosed price | |||
| Listed Drug | Form | Manner of administration | Brand |
|
1 | Alendronic acid with colecalciferol | Tablet 70 mg (as alendronate sodium) with 140 micrograms colecalciferol | Oral | Dronalen Plus | 31.82 |
2 | Alendronic acid with colecalciferol | Tablet 70 mg (as alendronate sodium) with 140 micrograms colecalciferol | Oral | Fosamax Plus 70 mg/140 mcg | 31.82 |
3 | Alendronic acid with colecalciferol | Tablet 70 mg (as alendronate sodium) with 70 micrograms colecalciferol | Oral | Fosamax Plus | 31.82 |
4 | Bicalutamide | Tablet 50 mg | Oral | APO‑‑Bicalutamide | 111.40 |
5 | Bicalutamide | Tablet 50 mg | Oral | Bicalutamide Ranbaxy | 111.40 |
6 | Bicalutamide | Tablet 50 mg | Oral | Bicalutamide‑‑GA | 111.40 |
7 | Bicalutamide | Tablet 50 mg | Oral | Calutex | 111.40 |
8 | Bicalutamide | Tablet 50 mg | Oral | Cosamide | 111.40 |
9 | Bicalutamide | Tablet 50 mg | Oral | Cosudex | 111.40 |
10 | Fosinopril with Hydrochlorothiazide | Tablet containing fosinopril sodium 10 mg with hydrochlorothiazide 12.5 mg | Oral | APO‑‑Fosinopril HCTZ 10/12.5 | 11.38 |
12 | Fosinopril with Hydrochlorothiazide | Tablet containing fosinopril sodium 10 mg with hydrochlorothiazide 12.5 mg | Oral | Fosinopril/HCTZ‑‑GA 10/12.5 | 11.38 |
13 | Fosinopril with Hydrochlorothiazide | Tablet containing fosinopril sodium 10 mg with hydrochlorothiazide 12.5 mg | Oral | Hyforil | 11.38 |
14 | Fosinopril with Hydrochlorothiazide | Tablet containing fosinopril sodium 10 mg with hydrochlorothiazide 12.5 mg | Oral | Monoplus 10/12.5 | 11.38 |
15 | Fosinopril with Hydrochlorothiazide | Tablet containing fosinopril sodium 20 mg with hydrochlorothiazide 12.5 mg | Oral | APO‑‑Fosinopril HCTZ 20/12.5 | 16.72 |
16 | Fosinopril with Hydrochlorothiazide | Tablet containing fosinopril sodium 20 mg with hydrochlorothiazide 12.5 mg | Oral | Fosetic 20/12.5 | 16.72 |
18 | Fosinopril with Hydrochlorothiazide | Tablet containing fosinopril sodium 20 mg with hydrochlorothiazide 12.5 mg | Oral | Fosinopril/HCTZ‑‑GA 20/12.5 | 16.72 |
19 | Fosinopril with Hydrochlorothiazide | Tablet containing fosinopril sodium 20 mg with hydrochlorothiazide 12.5 mg | Oral | Hyforil | 16.72 |
20 | Fosinopril with Hydrochlorothiazide | Tablet containing fosinopril sodium 20 mg with hydrochlorothiazide 12.5 mg | Oral | Monoplus 20/12.5 | 16.72 |
21 | Morphine | Capsule containing morphine sulfate 10 mg (containing sustained release pellets) | Oral | Kapanol | 6.23 |
22 | Morphine | Capsule containing morphine sulfate 100 mg (containing sustained release pellets) | Oral | Kapanol | 36.61 |
23 | Morphine | Capsule containing morphine sulfate 120 mg (controlled release) | Oral | MS Mono | 37.54 |
24 | Morphine | Capsule containing morphine sulfate 20 mg (containing sustained release pellets) | Oral | Kapanol | 9.06 |
25 | Morphine | Capsule containing morphine sulfate 30 mg (controlled release) | Oral | MS Mono | 12.06 |
26 | Morphine | Capsule containing morphine sulfate 50 mg (containing sustained release pellets) | Oral | Kapanol | 19.52 |
27 | Morphine | Capsule containing morphine sulfate 60 mg (controlled release) | Oral | MS Mono | 21.37 |
28 | Morphine | Capsule containing morphine sulfate 90 mg (controlled release) | Oral | MS Mono | 25.82 |
29 | Morphine | Oral solution containing morphine hydrochloride 10 mg per mL, 200 mL | Oral | Ordine 10 | 14.17 |
30 | Morphine | Oral solution containing morphine hydrochloride 2 mg per mL, 200 mL | Oral | Ordine 2 | 8.95 |
31 | Morphine | Oral solution containing morphine hydrochloride 5 mg per mL, 200 mL | Oral | Ordine 5 | 10.87 |
32 | Morphine | Sachet containing controlled release granules for oral suspension, containing morphine sulfate 100 mg per sachet | Oral | MS Contin Suspension 100 mg | 64.55 |
33 | Morphine | Sachet containing controlled release granules for oral suspension, containing morphine sulfate 20 mg per sachet | Oral | MS Contin Suspension 20 mg | 42.76 |
34 | Morphine | Sachet containing controlled release granules for oral suspension, containing morphine sulfate 200 mg per sachet | Oral | MS Contin Suspension 200 mg | 129.21 |
35 | Morphine | Sachet containing controlled release granules for oral suspension, containing morphine sulfate 30 mg per sachet | Oral | MS Contin Suspension 30 mg | 44.24 |
36 | Morphine | Sachet containing controlled release granules for oral suspension, containing morphine sulfate 60 mg per sachet | Oral | MS Contin Suspension 60 mg | 50.76 |
37 | Morphine | Tablet containing morphine sulfate 10 mg | Oral | Sevredol | 4.14 |
38 | Morphine | Tablet containing morphine sulfate 10 mg (controlled release) | Oral | APOTEX‑‑MORPHINE MR | 8.73 |
39 | Morphine | Tablet containing morphine sulfate 10 mg (controlled release) | Oral | Momex SR 10 | 8.73 |
40 | Morphine | Tablet containing morphine sulfate 10 mg (controlled release) | Oral | MS Contin | 8.73 |
41 | Morphine | Tablet containing morphine sulfate 100 mg (controlled release) | Oral | APOTEX‑‑MORPHINE MR | 52.97 |
42 | Morphine | Tablet containing morphine sulfate 100 mg (controlled release) | Oral | Momex SR 100 | 52.97 |
43 | Morphine | Tablet containing morphine sulfate 100 mg (controlled release) | Oral | MS Contin | 52.97 |
44 | Morphine | Tablet containing morphine sulfate 15 mg (controlled release) | Oral | MS Contin | 12.07 |
45 | Morphine | Tablet containing morphine sulfate 20 mg | Oral | Sevredol | 4.90 |
46 | Morphine | Tablet containing morphine sulfate 200 mg (controlled release) | Oral | MS Contin | 94.20 |
47 | Morphine | Tablet containing morphine sulfate 30 mg | Oral | Anamorph | 3.91 |
48 | Morphine | Tablet containing morphine sulfate 30 mg (controlled release) | Oral | APOTEX‑‑MORPHINE MR | 21.39 |
49 | Morphine | Tablet containing morphine sulfate 30 mg (controlled release) | Oral | Momex SR 30 | 21.39 |
50 | Morphine | Tablet containing morphine sulfate 30 mg (controlled release) | Oral | MS Contin | 21.39 |
51 | Morphine | Tablet containing morphine sulfate 5 mg (controlled release) | Oral | MS Contin | 6.77 |
52 | Morphine | Tablet containing morphine sulfate 60 mg (controlled release) | Oral | APOTEX‑‑MORPHINE MR | 37.55 |
53 | Morphine | Tablet containing morphine sulfate 60 mg (controlled release) | Oral | Momex SR 60 | 37.55 |
54 | Morphine | Tablet containing morphine sulfate 60 mg (controlled release) | Oral | MS Contin | 37.55 |
55 | Oxazepam | Tablet 15 mg | Oral | Alepam 15 | 0.82 |
56 | Oxazepam | Tablet 15 mg | Oral | Serepax | 0.82 |
57 | Oxazepam | Tablet 30 mg | Oral | Alepam 30 | 0.95 |
58 | Oxazepam | Tablet 30 mg | Oral | APO‑‑Oxazepam | 0.95 |
59 | Oxazepam | Tablet 30 mg | Oral | Murelax | 0.95 |
60 | Oxazepam | Tablet 30 mg | Oral | Serepax | 0.95 |
The endnotes provide details of the history of this legislation and its provisions. The following endnotes are included in each compilation:
Endnote 1—About the endnotes
Endnote 2—Abbreviation key
Endnote 3—Legislation history
Endnote 4—Amendment history
Endnote 5—Uncommenced amendments
Endnote 6—Modifications
Endnote 7—Misdescribed amendments
Endnote 8—Miscellaneous
If there is no information under a particular endnote, the word “none” will appear in square brackets after the endnote heading.
Abbreviation key—Endnote 2
The abbreviation key in this endnote sets out abbreviations that may be used in the endnotes.
Legislation history and amendment history—Endnotes 3 and 4
Amending laws are annotated in the legislation history and amendment history.
The legislation history in endnote 3 provides information about each law that has amended the compiled law. The information includes commencement information for amending laws and details of application, saving or transitional provisions that are not included in this compilation.
The amendment history in endnote 4 provides information about amendments at the provision level. It also includes information about any provisions that have expired or otherwise ceased to have effect in accordance with a provision of the compiled law.
Uncommenced amendments—Endnote 5
The effect of uncommenced amendments is not reflected in the text of the compiled law, but the text of the amendments is included in endnote 5.
Modifications—Endnote 6
If the compiled law is affected by a modification that is in force, details of the modification are included in endnote 6.
Misdescribed amendments—Endnote 7
An amendment is a misdescribed amendment if the effect of the amendment cannot be incorporated into the text of the compilation. Any misdescribed amendment is included in endnote 7.
Miscellaneous—Endnote 8
Endnote 8 includes any additional information that may be helpful for a reader of the compilation.
ad = added or inserted | pres = present |
am = amended | prev = previous |
c = clause(s) | (prev) = previously |
Ch = Chapter(s) | Pt = Part(s) |
def = definition(s) | r = regulation(s)/rule(s) |
Dict = Dictionary | Reg = Regulation/Regulations |
disallowed = disallowed by Parliament | reloc = relocated |
Div = Division(s) | renum = renumbered |
exp = expired or ceased to have effect | rep = repealed |
hdg = heading(s) | rs = repealed and substituted |
LI = Legislative Instrument | s = section(s) |
LIA = Legislative Instruments Act 2003 | Sch = Schedule(s) |
mod = modified/modification | Sdiv = Subdivision(s) |
No = Number(s) | SLI = Select Legislative Instrument |
o = order(s) | SR = Statutory Rules |
Ord = Ordinance | Sub-Ch = Sub-Chapter(s) |
orig = original | SubPt = Subpart(s) |
par = paragraph(s)/subparagraph(s) |
|
/sub--subparagraph(s) |
|
Title | FRLI registration | Commencement | Application, saving and transitional provisions |
PB 12 of 2012 | 26 Apr 2012 (see F2012L00931) | 27 Apr 2012 |
|
PB 51 of 2012 | 25 July 2012 (see F2012L01604) | 26 July 2012 | — |
ad. = added or inserted am. = amended rep. = repealed rs. = repealed and substituted exp. = expired or ceased to have effect | |
Provision affected | How affected |
Sch 1 |
|
Sch 1................... | am PB 51 of 2012 |
Endnote 5—Uncommenced amendments [none]
Endnote 6—Modifications [none]
Endnote 7—Misdescribed amendments [none]
Endnote 8—Miscellaneous [none]